Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
PODD - Insulet Corporation
Market Cap 18.73B P/E - EPS this Y 10.20% Ern Qtrly Grth 590.80%
Income 395.3M Forward P/E 126.76 EPS next Y 25.40% 50D Avg Chg -5.00%
Sales 1.87B PEG 4.76 EPS past 5Y 82.91% 200D Avg Chg -8.00%
Dividend N/A Price/Book 37.25 EPS next 5Y 16.25% 52W High Chg -20.00%
Recommedations 1.70 Quick Ratio 2.41 Shares Outstanding 70.12M 52W Low Chg 29.00%
Insider Own 0.34% ROA 6.85% Shares Float 69.75M Beta 1.21
Inst Own 101.87% ROE 50.93% Shares Shorted/Prior 2.99M/2.83M Price 268.74
Gross Margin 68.39% Profit Margin 21.11% Avg. Volume 569,746 Target Price 241.59
Oper. Margin 11.18% Earnings Date Nov 7 Volume 386,056 Change -0.81%
Healthcare | Medical Devices | United States
About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Insulet Corporation News
12/19/24 Insulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its Industry
12/13/24 Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
12/12/24 RMD or PODD: Which Is the Better Value Stock Right Now?
12/11/24 Inari Medical Stock Gets RS Rating Upgrade
12/09/24 Should You Continue to Retain Insulet Stock in Your Portfolio Now?
12/05/24 Insulet awarded $452M in EOFlow patent fight
12/04/24 Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court
12/03/24 Novocure Stock Earns 96 RS Rating
11/29/24 Here's Why Insulet (PODD) is a Strong Growth Stock
08:30 AM If You Invested $1000 in Insulet a Decade Ago, This is How Much It'd Be Worth Now
11/22/24 PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US
11/21/24 Insulet adds Abbott’s FreeStyle Libre 2 Plus to Omnipod 5’s compatibility roster
11/20/24 Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.
11/16/24 Insulet's (NASDAQ:PODD) Solid Profits Have Weak Fundamentals
11/15/24 Insulet to Present at Upcoming Investor Conferences
11/13/24 Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
11/13/24 Zacks.com featured highlights include NVIDIA, Insulet and Howmet Aerospace
11/12/24 Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More
11/12/24 Why Insulet (PODD) is a Top Growth Stock for the Long-Term
11/12/24 PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up
PODD Chatroom

User Image JInvestTrade Posted - 4 days ago

$SENS Directors have bought over 700,000 shares in the past couple of weeks. Another great vote of confidence for their product. The only 365 days CGM on the market. $DXCM last 10 days, $ABBV last 14 days. We need to bring awareness to those who are not aware of a CGM that can last 365 days. $TNDM $PODD

User Image darkpoolangel Posted - 1 week ago

$ABBV $DXCM $PODD $SENS $TNDM

User Image Alderson95 Posted - 1 week ago

$ABBV $DXCM $PODD $SENS $TNDM

User Image JInvestTrade Posted - 1 week ago

$SENS $SENS 625,000 shares have been purchased between the CEO and a board of director in the past couple of weeks. This is an increase in confidence on the Eversense 365 CGM product. $DXCM $ABBV $TNDM $PODD

User Image Alderson95 Posted - 1 week ago

$ABBV $DXCM $PODD $SENS $TNDM this guy knows his stuff $SENS going all the way up!!!

User Image JInvestTrade Posted - 1 week ago

$SENS Director buys 325,000 shares last Friday. Another vote of confidence from the C-suite. $DXCM $ABBV $TNDM $PODD. The only CGM that last 365 days. Other CGM last at most 14 days on a good day. Some fail within hours of putting on.

User Image StockAutoPro Posted - 1 week ago

$PODD: At $271.73. Bull call spread: Buy $270 call, sell $280 call (April) for $4, profiting from Insulet’s healthcare innovation.

User Image JInvestTrade Posted - 1 week ago

$SENS up 50% since Tim (CEO) purchased 315,000 shares. $DXCM $ABBV $TNDM $PODD

User Image St0ckman691 Posted - 1 week ago

$ADHC one of the 3 of the top stocks to watch in the Diabetes Tech space as we head into 2025. $MDT $PODD also worth keeping an eye on. https://allcapresearch.com/penny-stocks/f/the-growing-diabetes-management-and-tech-market?blogcategory=Pennystocks

User Image St0ckman691 Posted - 2 weeks ago

$MDT $PODD and $ADHC 3 hot stocks to watch heading into 2025 in the diabetes technology space. https://t.co/2qCwnf1iaA

User Image Stockprofiler Posted - 2 weeks ago

$ADHC Is included in this great article. Diabetes can be monitored faster now with GlucoGuard. "The Growing Diabetes Management and Technology Market: Three Key Stocks to Watch" $MDT $PODD $ADHC https://allcapresearch.com/f/the-growing-diabetes-management-and-tech-market

User Image firefox2778 Posted - 2 weeks ago

$ABBV $DXCM $PODD $SENS $TNDM

User Image JInvestTrade Posted - 2 weeks ago

$SENS Tim (CEO) bought 315,000 shares today. Vote of confidence if CEO is buying. $DXCM $ABBV $TNDM $PODD

User Image NorthstarT1D Posted - 2 weeks ago

$PODD good news for Podd. If they really get the money that would be a big windfall https://finance.yahoo.com/news/insulet-awarded-452m-eoflow-patent-121925653.html

User Image Bennieandthejets Posted - 3 weeks ago

$PODD is it unusual to see a stock break an intraday high multiple times in after hours trading? Does this indicate anything?

User Image JackDarwin Posted - 3 weeks ago

$PODD Bullish Engulfing Formed.

User Image danelfin Posted - 3 weeks ago

How sharp were our AI-powered ratings for $PODD in the past? Danelfin's 1247 past BUY signals for $PODD since Jan. 2017 achieved average positive performance, alpha, and win rate across various investing time frames. Not indicative of future results. https://danelfin.com/stock/PODD#track-record

User Image danelfin Posted - 3 weeks ago

$PODD chart since Jun 2024. Green dots are past AI-powered BUY signals. In the 3M forecast, the central dotted line is the most expected price path (+11.64%). The shaded area (-17.12% to +40.39%) is the expected price range based on prev. BUY signals (90% confidence level). Suggested $PODD trading parameters (3M horizon): entry $267, stop loss $247, take profit $344.46.

User Image danelfin Posted - 3 weeks ago

For our #AI, $PODD is a BUY (AI Score 9/10) based on the probability of beating the market in 3 months after analyzing 10,000 fundamental, technical, and sentiment stock features. Complete AI-powered $PODD analysis: https://danelfin.com/stock/PODD

User Image jheerdink Posted - 11/29/24

$MODD Additional & Significant Insider Buying Alert by CEO on Wednesday 11/27 and his Manchester Management Co! see sec filings https://www.sec.gov/Archives/edgar/data/1074871/000091957424006936/xslF345X05/ownership.xml $PODD $TNDM

User Image jheerdink Posted - 11/27/24

$MODD has surged 10.43% to $1.8000. Check it out on Yahoo Finance https://finance.yahoo.com/quote/MODD?p=MODD $podd

User Image LoveFest24 Posted - 1 month ago

$MODD well they got approved, now the hard work begins, the expensive work, the long, drawn out fight in the trenches to take market share from the big 3 $TNDM $PODD $MDT will it ever find customers, maybe but it will take years

User Image NVDAMillionaire Posted - 1 month ago

$PODD Insulet Corporation (PODD): A Pioneer Revolutionizing Diabetes Management https://beyondspx.com/article/insulet-corporation-podd-a-pioneer-revolutionizing-diabetes-management

User Image JInvestTrade Posted - 1 month ago

$SENS $DXCM $ABT $TNDM $PODD A great interview with $SENS marketing person on the technology, advantage over other CGM, procedure of $SENS 365 and convenience. https://youtu.be/bT4IU8arLT8?feature=shared

User Image JInvestTrade Posted - 1 month ago

$SENS $DXCM $PODD $ABT $TNDM

User Image JInvestTrade Posted - 1 month ago

$SENS $DXCM $TNDM $PODD $ABT

User Image FolikoInvest Posted - 1 month ago

$PODD Insulet Corporation's Q3 2024 results reveal a remarkable 25.7% sales increase, driven by the success of the Omnipod 5 insulin pump and its recent FDA clearance for type 2 diabetes management. With analysts projecting significant revenue growth and a bullish outlook, can Insulet maintain this momentum in a competitive landscape? https://folikoinsights.com/article/PODD/2024/11/21/insulet-stock-soars-over-12-after-strong-q3-earnings-and-positive-fda-clearance-for-omnipod-5-diabet?cid=9Q2iaQ0G2asLMXyN

User Image apvoguy Posted - 1 month ago

$PODD sell this stock…

User Image 30DeltaSpy Posted - 1 month ago

$PODD bullish

User Image JInvestTrade Posted - 1 month ago

$SENS $DXCM $ABT $TNDM $PODD

Analyst Ratings
Citigroup Buy Oct 1, 24
Canaccord Genuity Buy Sep 25, 24
Piper Sandler Overweight Sep 17, 24
Barclays Equal-Weight Aug 12, 24
BTIG Buy Aug 9, 24
UBS Neutral Aug 9, 24
Canaccord Genuity Buy Jul 23, 24
OTR Global Mixed Jun 10, 24
Redburn Atlantic Buy May 30, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Petrovic Shacey Director Director Nov 13 Sell 164.79 35,000 5,767,650 2,567 11/14/23
Petrovic Shacey Director Director Nov 13 Option 83.31 20,000 1,666,200 22,567 11/14/23
Singh Prem SVP, Global Operatio.. SVP, Global Operations Sep 19 Buy 168.92 1 169 4,032 09/21/23
Petrovic Shacey Advisor Advisor Feb 28 Sell 276.63 15,000 4,149,450 58,205 03/01/23
Petrovic Shacey Director Director Dec 15 Option 74.5 1,094 81,503 14,789 12/19/22
Petrovic Shacey President and CEO President and CEO Apr 02 Option 30.58 15,000 458,700 56,589 04/02/21